Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

External Validity of Risk Models: Use of Benchmark Values to Disentangle a Case-Mix Effect From Incorrect Coefficients

(2010) Y. Vergouwe et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

(2010) A. J. Vickers et al.   CLINICAL CANCER RESEARCH

Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporary Screened Cohort

(2010) Vítor Cavadas et al.   EUROPEAN UROLOGY

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison

(2008) Roderick C.N. van den Bergh et al.   BJU INTERNATIONAL

Validation of Pretreatment Nomograms for Predicting Indolent Prostate Cancer: Efficacy in Contemporary Urological Practice

(2008) Fei Dong et al.   JOURNAL OF UROLOGY

A graphical device to represent the outcomes of a logistic regression analysis

(2008) Ries Kranse et al.   PROSTATE